Dramatic improvement of severe acne pustolosa after adalimumab in a patient with ulcerative colitis

Key clinical message A 22‐year‐old male with extensive steroid‐dependent/azathioprine‐refractory ulcerative colitis and preexistent severe refractory acne pustolosa (AP) was successfully treated with adalimumab for both conditions. Severe AP could be considered a further indication, instead of a rel...

Full description

Saved in:
Bibliographic Details
Published in:Clinical case reports 2016-04, Vol.4 (4), p.348-350
Main Authors: Rispo, Antonio, Musto, Dario, Imperatore, Nicola, Testa, Anna, Rea, Matilde, Castiglione, Fabiana
Format: Article
Language:English
Subjects:
Acne
Acne pustolosa
adalimumab
Case Report
Case Reports
Drug dosages
Immunotherapy
Inflammation
Inflammatory bowel disease
inflammatory bowel diseases
infliximab
Monoclonal antibodies
Pathogenesis
Patients
Psoriasis
Quality of life
Steroids
tumor necrosis factor alpha
Tumor necrosis factor-TNF
ulcerative colitis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Key clinical message A 22‐year‐old male with extensive steroid‐dependent/azathioprine‐refractory ulcerative colitis and preexistent severe refractory acne pustolosa (AP) was successfully treated with adalimumab for both conditions. Severe AP could be considered a further indication, instead of a relative restriction, to anti‐TNFα in steroid‐dependent IBD patients needing therapy with this class of drugs. A 22‐year‐old male with extensive steroid‐dependent/azathioprine‐refractory ulcerative colitis and preexistent severe refractory acne pustolosa (AP) was successfully treated with adalimumab for both conditions. Severe AP could be considered a further indication, instead of a relative restriction, to anti‐TNFα in steroid‐dependent IBD patients needing therapy with this class of drugs.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.520